Abstract
Across Europe there is much variation in both the neurology and palliative care services provided for people with progressive neurological disease. However there is increasing interest and collaboration in some areas. These initiatives are being developed across Europe, with improvement in the end of life care for patients and families.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
WHO. World Health Organisation Regional Office for Europe website. World Health Organisation; 2012 [cited Feb 8 2012]. Available from: http://www.euro.who.int/en/where-we-work.
Europe Co. The Council of Europe website. 2012 [cited Feb 1 2012]. Available from: http://www.coe.int/lportal/web/coe-portal.
EUROPA.EU. The European Union Portal. 2012 [cited Feb 1 2012]. Available from: http://europa.eu/about-eu/countries/index_it.htm.
De Conno F, Blumhuber H, Rocafort J. The development of palliative medicine in Europe. In: Bruera E, Higginson I, Ripamonti C, Von Gunten C, editors. Textbook of palliative medicine. 1st ed. London: Hodder Arnold; 2009. p. 12–21.
Borasio GD, Voltz R. Palliative care in neurology. J Palliat Care. 2005;21(3):188–9.
Saunders C, Walsh D, Smith M. Hospice care in motor neurone disease. In: Saunders C, Summers D, Teller N, editors. Hospice: the living idea. London: Edward Arnold; 1981. p. 126–55.
Voltz R, Bernat JL, Borasio GD, Maddocks I, Oliver D, Portenoy RK. (editors). Palliative care in neurology Oxford: Oxford University Press; 2004.
Ringel SP, Murphy JR, Alderson MK, Bryan W, England JD, Miller RG, et al. The natural history of amyotrophic lateral sclerosis. Neurology. 1993;43(7):1316–22.
Clark D. Cicely Saunders. Founder of the hospice movement. Selected letters 1959–1999. Oxford: Oxford University Press; 2002.
Norris FH, Smith RA, Denys EH. Motor neurone disease: towards better care. Br Med J (Clin Res Ed). 1985;291(6490):259–62.
O’Brien T, Kelly M, Saunders C. Motor neurone disease: a hospice perspective. BMJ. 1992;304(6825):471–3.
Neudert C, Oliver D, Wasner M, Borasio GD. The course of the terminal phase in patients with amyotrophic lateral sclerosis. J Neurol. 2001;248(7):612–6.
Miller RG, Rosenberg JA, Gelinas DF, Mitsumoto H, Newman D, Sufit R, et al. Practice parameter: the care of the patient with amyotrophic lateral sclerosis (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology: ALS Practice Parameters Task Force. Neurology. 1999;52(7):1311–23.
Voltz R, Borasio GD. Palliative therapy in the terminal stage of neurological disease. J Neurol. 1997;244 Suppl 4:S2–10.
Chio A, Bottacchi E, Buffa C, Mutani R, Mora G. Positive effects of tertiary centres for amyotrophic lateral sclerosis on outcome and use of hospital facilities. J Neurol Neurosurg Psychiatry. 2006;77(8):948–50.
Traynor BJ, Alexander M, Corr B, Frost E, Hardiman O. Effects of a multidisciplinary ALS clinic on survival. J Neurol Neurosurg Psychiatry. 2003;74:1258–61.
Golla H, Galushko M, Pfaff H, Voltz R. Unmet needs of severely affected multiple sclerosis patients: the health professionals’ view. Palliat Med. 2011;26(2):139–51.
Edmonds P, Vivat B, Burman R, Silber E, Higginson IJ. Loss and change: experiences of people severely affected by multiple sclerosis. Palliat Med. 2007;21(2):101–7.
Higginson IJ, Hart S, Silber E, Burman R, Edmonds P. Symptom prevalence and severity in people severely affected by multiple sclerosis. J Palliat Care. 2006;22(3):158–65.
Edmonds P, Hart S, Wei G, Vivat B, Burman R, Silber E. Palliative care for people severely affected by multiple sclerosis: evaluation of a novel palliative care service. Mult Scler. 2010;16(5):627–36.
Higginson IJ, McCrone P, Hart SR, Burman R, Silber E, Edmonds PM. Is short-term palliative care cost-effective in multiple sclerosis? A randomized phase II trial. J Pain Symptom Manage. 2009;38(6):816–26.
Lee MA, Walker RW, Hildreth TJ, Prentice WM. A survey of pain in idiopathic Parkinson’s disease. J Pain Symptom Manage. 2006;32(5):462–9.
Lee MA, Walker RW, Hildreth AJ, Prentice WM. Individualized assessment of quality of life in idiopathic Parkinson’s disease. Mov Disord. 2006;21(11):1929–34.
Lee MA, Prentice WM, Hildreth AJ, Walker RW. Measuring symptom load in Idiopathic Parkinson’s disease. Parkinsonism Relat Disord. 2007;13(5):284–9.
EAPC. People with neurological disease. 2012 [cited Feb 8 2012]. Available from: http://www.eapcnet.eu/Themes/Specificgroups/Peoplewithneurologicaldisease/Guidelinescurriculumtaskforce.aspx.
NHS. Improving end of life care in neurological disease. A framework for implementation. 2010 [cited Feb 8 2012]. Available from: http://www.endoflifecareforadults.nhs.uk/publications/end-of-life-care-in-long-term-neurological-conditions-a-framework.
Law 38,15.3.10. Republic of Italy: Disposizioni per garantire l’accesso alle cure palliative ed alla terapia del dolore. 2010. Access at: http://www.parlamento.it/parlam/leggi/10038l.htm.
Defanti CA. Study Group of Bioethics and Palliative Care in Neurology: program document. Neurol Sci. 2000;21(5):261–71.
Causarano R. Le cure palliative in neurologia: come, dove e quando. Neurol Sci. 2005;26:S127–31.
Defanti CA. Come muore il malato neurologico? Neurol Sci. 2005;26:S109–13.
Bonito V, Caraceni A, Borghi L, Marcello N, Mori M, Porteri C, et al. The clinical and ethical appropriateness of sedation in palliative neurological treatments. Neurol Sci. 2005;26(5):370–85.
Bonito V. Le dichiarazione anticipate in neurologia. Neurol Sci. 2005;26:S121–6.
Bonito V, Primavera A, Borghi L, Mori M, Defanti CA. The discontinuation of life support measures in patients in a permanent vegetative state. Neurol Sci. 2002;23(3):131–9.
Congedo M, Causarano RI, Alberti F, Bonito V, Borghi L, Colombi L, et al. Ethical issues in end of life treatments for patients with dementia. Eur J Neurol. 2010;17(6):774–9.
Chio A, Mora G, Leone M, Mazzini L, Cocito D, Giordana MT, et al. Early symptom progression rate is related to ALS outcome: a prospective population-based study. Neurology. 2002;59(1):99–103.
Veronese S, Oliver D, editors. Developing and evaluating a specialist palliative care service for people with neurodegenerative disorders. An application of the MRC framework for the design and the evaluation of complex interventions. In: 12th conference of the European Association for Palliative Care, Lisbon, 2011.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag London
About this chapter
Cite this chapter
Veronese, S. (2013). International Aspects of Care: Europe. In: Oliver, D. (eds) End of Life Care in Neurological Disease. Springer, London. https://doi.org/10.1007/978-0-85729-682-5_12
Download citation
DOI: https://doi.org/10.1007/978-0-85729-682-5_12
Published:
Publisher Name: Springer, London
Print ISBN: 978-0-85729-681-8
Online ISBN: 978-0-85729-682-5
eBook Packages: MedicineMedicine (R0)